IPA

Q: What is the price of ImmunoPrecise Antibodies (IPA) today?

The price of ImmunoPrecise Antibodies (IPA) today is $ 0.00, with return of 0% compared to the last year. The price of ImmunoPrecise Antibodies (IPA) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of ImmunoPrecise Antibodies (IPA) and international markets.

Q: When does ImmunoPrecise Antibodies (IPA) pay dividends?

ImmunoPrecise Antibodies (IPA) did not distribute dividends in the last year.

Q: Is ImmunoPrecise Antibodies (IPA) worth it?

Currently, ImmunoPrecise Antibodies (IPA) is priced at $ 0.00, with a P/E of -5.35%, representing a deviation of -489% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy ImmunoPrecise Antibodies (IPA) stock?

Investing in stocks of ImmunoPrecise Antibodies (IPA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of ImmunoPrecise Antibodies (IPA) yield today?

The yield of ImmunoPrecise Antibodies (IPA) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of ImmunoPrecise Antibodies (IPA) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ImmunoPrecise Antibodies Ltd.

Price

$ -

return (12m)

0.00%

p/e

-5.35

p/bv

6.31

DIVIDEND YIELD

0.00%

IPA price

IPA

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment IPA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals IPA

review the fundamentals of ImmunoPrecise Antibodies shares

P/E

-5.35

Sector: -5.82 Industry: -5.82

P/S (PSR)

5.70

Sector: -4.74 Industry: -4.74

P/BV

6.31

Sector: 1.40 Industry: 1.40

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-62.66%

Sector: -72.38% Industry: -72.38%

ROE

-117.87%

Sector: -84.15% Industry: -84.15%

ROIC

-23.19%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

-100.00%

Sector: -46.16% Industry: -46.16%

GROSS MARGIN

59.70%

Sector: 35.92% Industry: 35.92%

OPERATING MARGIN

-34.31%

Sector: -46.05% Industry: -46.05%

EV/EBITDA

-5.77

Sector: -5.52 Industry: -5.52

EV/EBIT

-4.89

Sector: -5.77 Industry: -5.77

PRICE-TO-ASSETS

3.35

Sector: 1.13 Industry: 1.13

BVPS

0.38

Sector: 1.63 Industry: 1.63

EPS

-0.44

Sector: -2.73 Industry: -2.73

EQUITY-TO-ASSETS RATIO

0.53

Sector: 0.32 Industry: 0.32

LIABILITIES / ASSETS

0.47

Sector: 0.33 Industry: 0.33

CAGR REVENUE 5 YEARS

4.16%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

6.31%

Sector: - Industry: -

Fundamentals IPA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	25.06	-1,098.65	-4,383.84%	0.36%	$ 108.77 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

IPA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd.

Average Investor10 user rating

4.0 (1 people)

United States

43 years

Founded: 1983

2011

Time since IPO - 15 years

73

Employees

The Company ImmunoPrecise Antibodies Ltd. (United States), is listed on Nasdaq with a market value of $ 106.65 Millions, having an equity of $ 16.90 Millions.

With a total of 73 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 18.71 Millions, which generated a loss in the amount of $ -19.92 Millions.

As for its main indicators, the Company has a P/E ratio of -5.35, a P/BV ratio of 6.31 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker IPA.

Market cap

$ 106.65 Millions

Net worth

$ 16.90 Millions

US$ 16,900,000.00

Assets

$ 31.79 Millions

US$ 31,790,000.00

Total Shares Outstanding

45.00 Millions

45,000,000

Average Daily Trading Volume

$ 1.80 Million

US$ 1,799,994.00

Sector

Health Care

Industry

Biotechnology

IPA

IPA revenue and profits

Financial Results IPA

DRAG THE FRAME TO SEE MORE DATA

IPA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 29,96% (12M)

P/E

25.06

0.36%

ROE

-4,383.84%

P/BV

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 28.32 32,24% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 208.84 16,32% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 29,96% (12 M)

P/L

25.06

0.36%

ROE

-4,383.84%

P/VP

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 28.32 32,24% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 208.84 16,32% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of ImmunoPrecise Antibodies (IPA) today?

The price of ImmunoPrecise Antibodies (IPA) today is $ 0.00, with return of 0% compared to the last year. The price of ImmunoPrecise Antibodies (IPA) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of ImmunoPrecise Antibodies (IPA) and international markets.

When does ImmunoPrecise Antibodies (IPA) pay dividends?

ImmunoPrecise Antibodies (IPA) did not distribute dividends in the last year.

Is ImmunoPrecise Antibodies (IPA) worth it?

Currently, ImmunoPrecise Antibodies (IPA) is priced at $ 0.00, with a P/E of -5.35%, representing a deviation of -489% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy ImmunoPrecise Antibodies (IPA) stock?

Investing in stocks of ImmunoPrecise Antibodies (IPA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of ImmunoPrecise Antibodies (IPA) yield today?

The yield of ImmunoPrecise Antibodies (IPA) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of ImmunoPrecise Antibodies (IPA) today, the total investment would be $ 0.00, based on the current price of $ 0.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.00
In 5 years: $ 0.00
In 10 years: $ 0.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

IPA

ImmunoPrecise Antibodies Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IPA

review the fundamentals of ImmunoPrecise Antibodies shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd.

United States

43 years

2011

73

PROFIT X PRICE IPA

Financial Results IPA

IPA cash flow

Asset, Revenue and Profit Growth - IPA

IPA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions